Published in Pain and Central Nervous System Week, March 11th, 2002
The trial will assess the impact of a single injection of secretin or a placebo on the activity of the amygdala, a social integration center in the brain, in 12 healthy adults. Subjects will also perform facial recognition tasks to determine if a single injection of secretin affects this aspect of social awareness. This study is part of a comprehensive clinical program to evaluate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.